Given the notable detrimental effects on metabolism observed in our KO model, these data suggest that TSHR down‐regulation in obesity may contribute in the manifestation of a range of metabolic abnormalities, including glucose intolerance, altered adipokine profile, and dysfunctional thermogenesis. Here, TSHR is linked to obesity due to melanocortin 4 receptor deficiency.